Spain· ES:61369
TARKA 180 mg/ 2 mg CAPSULAS DE LIBERACION MODIFICADA
A medicinal product containing trandolapril + verapamilo, registered in Spain by Viatris Healthcare Limited.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- trandolapril + verapamilo
- Manufacturer
- Viatris Healthcare Limited
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo67437428EUR 22.25
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Trandolapril + verapamilo in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTARKAVIATRIS HEALTHCARE LIMITED, Dublin
- NetherlandsTarka 180 mg/2 mg, capsules met gereguleerde afgifteViatris Healthcare Limited
- United KingdomTarka modified-release capsulesAbbott Laboratories Ltd
- United StatesTrandolapril and Verapamil HydrochlorideGlenmark Pharmaceuticals Inc., USA
- FranceTARKA LP 180 mg/2 mg, comprimé pelliculé à libération prolongéeVIATRIS MEDICAL
- FinlandTarkaAbbott Scandinavia AB
- SwitzerlandTarka, FilmtablettenViatris Pharma GmbH
- GermanyTarkaViatris Healthcare Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Bulgaria · Таркa, Тарка
- Czechia · Tarka
- Germany · Tarka
- Estonia · Tarka
- France · Tarka Lp
- Croatia · Tarka
- Hungary · Tarka
- Lithuania · Tarka
- Luxembourg · Tarka
- Latvia · Tarka
- Netherlands · Tarka
- Romania · Tarka
- Slovenia · Tarka
- Slovakia · Tarka
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/896f7bb3-51db-4fa7-acc3-125f0d3c49a9 GET /v1/drugs/896f7bb3-51db-4fa7-acc3-125f0d3c49a9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":857170800000}",
"nregistro": "61369",
"substance": "trandolapril + verapamilo"
}See everything about trandolapril + verapamilo.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.